C4 Therapeutics' Cash, Cash Equivalents and Marketable Securities Total $299.2M As Of March 31, 2024; Expected To Provide Runway Into 2027
C4 Therapeutics' Cash, Cash Equivalents and Marketable Securities Total $299.2M As Of March 31, 2024; Expected To Provide Runway Into 2027
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.